Relationship of Vasoactive Peptide Levels to Portal Pressure and Patient Outcomes in Patients With Hepatic Cirrhosis
1 other identifier
observational
N/A
1 country
1
Brief Summary
Investigate vasoactive medicators in portal hypertension on stored sera
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 11, 2005
CompletedFirst Posted
Study publicly available on registry
September 14, 2005
CompletedOctober 4, 2006
September 1, 2005
September 11, 2005
October 3, 2006
Conditions
Eligibility Criteria
You may qualify if:
- portal hypertension
You may not qualify if:
- Nil
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Bayside Healthlead
Study Sites (1)
Alfred Hospital
Melbourne, Victoria, 3181, Australia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
William W Kemp, MBBS FRACP
The Alfred
Study Design
- Study Type
- observational
- Observational Model
- DEFINED POPULATION
- Time Perspective
- OTHER
- Sponsor Type
- OTHER GOV
Study Record Dates
First Submitted
September 11, 2005
First Posted
September 14, 2005
Last Updated
October 4, 2006
Record last verified: 2005-09